antivaginolysin mAbs (Uab Profarma/Institute of Biotechnology IBT)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantivaginolysin mAbs (Uab Profarma/Institute of Biotechnology IBT)
Drug Alias Nameantivaginolysin monoclonal antibodies (Uab Profarma/Institute of Biotechnology IBT)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaginosis, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryLithuania
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProfarma UAB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute of Biotechnology IBTProfarma UAB
Active IndicationsN/A
Inactive IndicationsVaginosis, Bacterial

Other Information

ATC CodeN/A
Related LinksN/A